StableX (SBLX) director granted 22,723 options at $6.25
StableX Technologies, Inc. (SBLX) reported an insider equity award on a Form 4.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
StableX Technologies, Inc. (SBLX) reported an insider equity award on a Form 4. Director Greg Schiffman received an employee stock option to purchase 22,723 shares of common stock at an exercise price of $6.25 per share on 10/31/2025. The option expires on 10/31/2035.
Vesting is split: 75% vested on the grant date, and the remaining 25% will vest on December 31, 2025, conditioned on continued service with the company. Following the reported transaction, the filing shows 22,723 derivative securities beneficially owned, held directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (Right to Buy | 22,723 | $0.00 | $0.00 |
Footnotes (1)
- F1. The stock options vest as follows: (i) 75% vested upon the date of grant; and (ii) 25% will vest on December 31, 2025, provided that the Reporting Person remains employed by or providing services to the Issuer on the applicable vesting date.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did StableX (SBLX) disclose in this Form 4?
What is the vesting schedule for the SBLX option grant?
What is the expiration date of the StableX option?
How many derivative securities are shown as beneficially owned after the transaction?
What is the ownership form reported for the option?
Who is the reporting person on this SBLX Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.